Senior insider sale
MOONLAKE IMMUNOTHERAPEUTICS — senior position signals high conviction
$1.15M
23.50K shares
What this filing means
MOUKHEIBIR CATHERINE plans to sell 23.50K shares of MOONLAKE IMMUNOTHERAPEUTICS valued at approximately $1.15M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/3/2025ACC: 0001959173-25-004458
Director
Since Apr 2022
23.50K
Shares to sell
$1.15M
Approx. market value
23.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Option Granted - 04/06/2022
Cash
7/3/2025
23.50KTotal acquired23.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/3/2025 | Option Granted - 04/06/2022 Cash | 23.50K | — |
| Total | 23.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
23.50K
Market value
$1.15M
7/3/2025
Total
Units
23.50K
Value
$1.15M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/3/2025 | 23.50K | $1.15M | NASDAQ | Planned |
| Total | 23.50K | $1.15M | ||